| 40:18.0.1.1.8.6.1.1 | SECTION 79.50
| 79.50 Definitions. | |
| 40:18.0.1.1.8.6.1.2 | SECTION 79.51
| 79.51 General requirements and provisions. | |
| 40:18.0.1.1.8.6.1.3 | SECTION 79.52
| 79.52 Tier 1. | |
| 40:18.0.1.1.8.6.1.4 | SECTION 79.53
| 79.53 Tier 2. | |
| 40:18.0.1.1.8.6.1.5 | SECTION 79.54
| 79.54 Tier 3. | |
| 40:18.0.1.1.8.6.1.6 | SECTION 79.55
| 79.55 Base fuel specifications. | |
| 40:18.0.1.1.8.6.1.7 | SECTION 79.56
| 79.56 Fuel and fuel additive grouping system. | |
| 40:18.0.1.1.8.6.1.8 | SECTION 79.57
| 79.57 Emission generation. | |
| 40:18.0.1.1.8.6.1.9 | SECTION 79.58
| 79.58 Special provisions. | |
| 40:18.0.1.1.8.6.1.10 | SECTION 79.59
| 79.59 Reporting requirements. | |
| 40:18.0.1.1.8.6.1.11 | SECTION 79.60
| 79.60 Good laboratory practices (GLP) standards for inhalation exposure health effects testing. | |
| 40:18.0.1.1.8.6.1.12 | SECTION 79.61
| 79.61 Vehicle emissions inhalation exposure guideline. | |
| 40:18.0.1.1.8.6.1.13 | SECTION 79.62
| 79.62 Subchronic toxicity study with specific health effect assessments. | |
| 40:18.0.1.1.8.6.1.14 | SECTION 79.63
| 79.63 Fertility assessment/teratology. | |
| 40:18.0.1.1.8.6.1.15 | SECTION 79.64
| 79.64 In vivo micronucleus assay. | |
| 40:18.0.1.1.8.6.1.16 | SECTION 79.65
| 79.65 In vivo sister chromatid exchange assay. | |
| 40:18.0.1.1.8.6.1.17 | SECTION 79.66
| 79.66 Neuropathology assessment. | |
| 40:18.0.1.1.8.6.1.18 | SECTION 79.67
| 79.67 Glial fibrillary acidic protein assay. | |
| 40:18.0.1.1.8.6.1.19 | SECTION 79.68
| 79.68 Salmonella typhimurium reverse mutation assay. | |